The recent market downturn has left many investors feeling uncertain. Last week, all three major indexes – the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite – closed with losses. The fear of further interest rate hikes from the Federal Reserve, along with disappointing earnings reports and geopolitical tensions, has contributed to the market turbulence.
However, here at Zacks, we provide investors with unbiased guidance on how to navigate these challenging market conditions. With our time-tested methodologies and proven track record, we’ve achieved significant success in guiding investors over the past three months.
Clearwater Analytics and Molina Healthcare: Zacks Rank Upgrades
One of our notable achievements is the upgrade of Clearwater Analytics Holdings, Inc. (CWAN) and Molina Healthcare, Inc. (MOH) to a Zacks Rank #2 (Buy). Since the upgrades, Clearwater Analytics has gained 12.3%, while Molina Healthcare has returned 11.1%.
Our Zacks Rank system has shown a strong correlation between earnings estimate revisions and near-term stock price movements. Our hypothetical portfolio of Zacks Rank #1 (Strong Buy) stocks has outperformed the S&P 500 index this year, showcasing the effectiveness of our ranking system.
Zacks Recommendation Upgrades: MakeMyTrip and Kimbell Royalty
We have also recently upgraded the recommendations for MakeMyTrip Limited (MMYT) and Kimbell Royalty Partners, LP (KRP) to Outperform. Since the upgrades, MakeMyTrip has advanced 11.6%, and Kimbell Royalty has gained 9.6%. Our Zacks Recommendation aims to predict performance over the next 6 to 12 months based on trends in earnings estimate revisions.
Zacks Focus List: ICF International and Lululemon Athletica
ICF International, Inc. (ICFI) and Lululemon Athletica Inc. (LULU), two stocks included in our Zacks Focus List, have produced impressive returns. ICF International has gained 8.4% over the past 12 weeks since being added to the Focus List, while Lululemon Athletica has returned 6.8%. The Zacks Focus List has consistently outperformed the S&P 500 index, generating significant returns for our investors.
Zacks ECAP Stocks: Novo Nordisk and Fair Isaac
Novo Nordisk A/S (NVO) and Fair Isaac Corporation (FICO), part of our Earnings Certain Admiral Portfolio (ECAP), have delivered substantial gains. Novo Nordisk has jumped 22.9% over the past 12 weeks, while Fair Isaac has returned 11.2%. The ECAP portfolio is designed to minimize capital loss by holding shares of companies with proven earnings streams.
Zacks ECDP Stocks: Amgen and UnitedHealth
Amgen Inc. (AMGN) and UnitedHealth Group Incorporated (UNH), included in our Earnings Certain Dividend Portfolio (ECDP), have outperformed their peers. Amgen has returned 18.1% over the past 12 weeks, and UnitedHealth has climbed 4.3%. The ECDP portfolio offers stability and income from quality dividend stocks.
Zacks Top 10 Stocks: Fabrinet’s Solid Performance
Fabrinet (FN), one of our Zacks Top 10 Stocks for 2023, has delivered exceptional returns. The stock has gained 25.4% year to date, outperforming the S&P 500 Index. Our Top 10 portfolio has consistently outperformed the market, generating significant annualized returns.
Unlock the Future with ChatGPT Stocks
If you’re looking to invest in the wave of the future, we have hand-picked five stocks with sky-high growth potential in the field of Artificial Intelligence. Automation, innovation, and incredible growth projections make these stocks an exciting opportunity for investors. Don’t miss out on the chance to be part of this transformative industry.
At Zacks, we are committed to providing investors with the tools, research, and analysis necessary to beat the market. Our proven methodologies, focus lists, and portfolio strategies have consistently delivered strong returns. Join us and gain full access to our powerful resources.
Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect those of Nasdaq, Inc.